Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sonya Carvalho Neto"'
Autor:
Sonya Carvalho Neto, Ahmad Salti, Zoe Puschban, Nadia Stefanova, Roxana Nat, Georg Dechant, Gregor K Wenning
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50178 (2012)
Evidence from carefully conducted open label clinical trials suggested that therapeutic benefit can be achieved by grafting fetal dopaminergic (DAergic) neurons derived from ventral mesencephalon (VM) into the denervated striatum of Parkinson's disea
Externí odkaz:
https://doaj.org/article/36ac07ea43b54f70b388bbd62b9ec8a2
Publikováno v:
Journal of Neural Transmission. 123:1247-1254
Leptin is an anorexigenic hormone that acts via its receptor (LepR) to regulate the hypothalamic arcuate nucleus circuitry to mediate energy homeostasis and feeding behavior. Moreover, leptin decreases the reward value of natural and artificial rewar
Autor:
Andreas Moser, Ulrich G. Hofmann, Kevin Joseph, Sonya Carvalho Neto, Volker M. Tronnier, Ramya Varatharajan
Publikováno v:
The Open Neuroscience Journal. 8:14-20
Electrical high frequency stimulation (HFS) in the subthalamic nucleus (STN) has been shown to have a thera- peutic effect in several movement disorders. But, debilitating psychiatric effects like depression and suicidality are occa- sionally seen an
Publikováno v:
Stem Cells and Development. 22:397-411
Dopaminergic neurons derived from pluripotent stem cells are among the best investigated products of in vitro stem cell differentiation owing to their potential use for neurorestorative therapy of Parkinson's disease. However, the classical different
Autor:
Sonya Carvalho Neto, Ulrich G. Hofmann, Andreas Moser, Kevin Joseph, Volker M. Tronnier, Ramya Varatharajan
Publikováno v:
Neurochemistry international. 90
Deep brain stimulation (DBS) of the nucleus accumbens (NAc) is an effective treatment option for those affected by obsessive compulsive disorder, who do not respond to pharmacological treatment strategies. Yet, little is known about the mechanism by
Publikováno v:
Open Journal of Neuroscience. 5:1
Autor:
Zoe Puschban, Roxana Nat, Gregor K. Wenning, Nadia Stefanova, Sonya Carvalho Neto, Georg Dechant, Ahmad Salti
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e50178 (2012)
PLoS ONE, Vol 7, Iss 11, p e50178 (2012)
Evidence from carefully conducted open label clinical trials suggested that therapeutic benefit can be achieved by grafting fetal dopaminergic (DAergic) neurons derived from ventral mesencephalon (VM) into the denervated striatum of Parkinson's disea